[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100543013":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":32,"responsibleParty":45,"collaborators":20,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":20,"enrollmentInfo":57,"targetDuration":20,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":71,"whyStopped":20,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Navy General Hospital, Beijing","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"mVTEA Management Group","EXPERIMENTAL","Patients with high-risk of VTE will be discharged with mVTEA-assisted patient-centered VTE management.",[13],"Device: mobile venous thromboembolism application (mVTEA)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","mobile venous thromboembolism application (mVTEA)","mVTEA will assist in the management of patients with high-risk of VTE during the post-hospitalization follow-up phase. The mVTEA's doctor terminal automatically sends VTE-related health education materials in different frequencies and contents based on the patient's knowledge of VTE prevention and treatment, as well as their risk of thrombosis and bleeding during follow-up. In addition, thrombosis physicians on the mVTEA's doctor terminal can deliver health education to patients based on their condition. This can be done through the mVTEA doctor-patient communication module, which includes text, voice, and video communication.",[9],null,[22],{"name":23,"affiliation":24,"role":25},"YU-TAO GUO, Doctor","Sixth Medical Center of Chinese PLA General Hospital","STUDY_CHAIR",[27],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},"ZHI-GENG JIN, Doctor","CONTACT","8615801402223","lwgjzg@163.com",[33],{"facility":24,"status":20,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":20},"Beijing","Beijing Municipality","100048","China","CN",{"type":40,"coordinates":41},"Point",[42,43],116.39723,39.9075,{"lat":43,"lon":42},{"type":46,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100543013","smart-technology-facilitated-patient-centered-venous-thromboembolism-management-100543013",false,"NCT06350344","Smart Technology Facilitated Patient-centered Venous Thromboembolism Management","Smart Technology Facilitated Patient-centered Venous Thromboembolism Management: A Multicenter Cohort Study","SmaVTE-COR","Inclusion Criteria:\n\n* Inpatients ≥18 years of age at admission;\n* At high-risk of VTE at discharge: Padua score ≥4 for medical patients and Caprini score ≥5 for surgical patients;\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Diagnosis of VTE at discharge;\n* Mental disorder or combination of other serious diseases leading to incapacity for independent living;\n* Inability to use smartphones, computer tablets and other smart devices;\n* Being pregnant or breastfeeding;\n* Have participated in similar trials or are undergoing other clinical trials.","ALL","18 Years",{"count":58,"type":59},2353,"ESTIMATED","INTERVENTIONAL",[62],"NA","Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention.\n\nThe objective of this study is to observe the long-term effect of mobile venous thromboembolism application (mVTEA) based patient-centered management of venous thromboembolism (VTE) on thromboprophylaxis, and establish a foundation of evidence for managing patients with high-risk VTE.",[65,66,67],"Venous Thromboembolism","Digital Health","Health Education",[65,69,70,67],"Mobile Health","Prophylaxis","NOT_YET_RECRUITING","2024-07-15",{"date":74,"type":75},"2024-07-17","ACTUAL",{"date":77,"type":59},"2024-11-01",{"date":79,"type":59},"2027-10-31",{"name":5,"class":6},1]